We use the FFPE patient RNA extracted to run the OncoPrism-HNSCC ICI response prediction test as input to additionally test for the presence of NTRK1/2/3 and ALK gene fusions. This evidence concerns the gene ALK and head and neck squamous cell carcinoma.